��������

Hitto Kaufmann is the Chief Research and Development Officer at Hansa Biopharma, having previously served as Chief Scientific Officer at Pieris Pharmaceuticals. With over 20 years of experience in the biopharma industry, Hitto has developed more than 100 therapeutic entities and successfully advanced pipelines by steering strategic partnerships. Hitto's leadership includes building and leading diverse global teams at organizations such as Boehringer Ingelheim and Sanofi, where they contributed to significant advancements in biotherapeutics development. Currently, Hitto is also a member of the Scientific Advisory Board at iBET.